wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26782270-0E636A80-E842-49CE-A6EC-1B1E18BF0660
Q26782270-0E636A80-E842-49CE-A6EC-1B1E18BF0660
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26782270-0E636A80-E842-49CE-A6EC-1B1E18BF0660
Novel Targeted Agents in Hodgkin and Non-Hodgkin Lymphoma Therapy
P2860
Q26782270-0E636A80-E842-49CE-A6EC-1B1E18BF0660
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26782270-0E636A80-E842-49CE-A6EC-1B1E18BF0660
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f08b2597e64459ce1192dbf6437f78129dfd8688
P2860
Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies